Discovery of pyrimidine-2,4-diamine analogues as efficiency anticancer drug by targeting GTSE1
Bioorganic Chemistry · 2024-10 · 151 · 107700
DOI: 10.1016/j.bioorg.2024.107700 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioorganic Chemistry, 2024-10. Verfasst von Sunhui Xing und 9 weiteren Autor:innen. Beteiligte Einrichtung: Chemical Biology Research Center at School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325035, Zhejiang, China. Hauptthemen laut MEDLINE: Antineoplastic Agents, Cell Proliferation, Pyrimidines, Drug Screening Assays, Antitumor. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Natural Science Foundation of Zhejiang Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
A series of pyrimidine-2,4-diamine analogues were designed and synthesized. Their anticancer activity and the underlying mechanism against colorectal cancer (CRC) HCT116 cells and non-small cell lung cancer (NSCLC) A549 cells were investigated. The results demonstrated that the active compound Y18 significantly inhibited cancer cell proliferation by inducing robust cell cycle arrest and cell senescence through the persistence of DNA damage. Additionally, Y18 exhibited significant inhibitory effects on the adhesion, migration and invasion of cancer cells in vitro. Mechanistically, Y18 achieved these anticancer activities by suppressing GTSE1 transcription and expression. Y18 also effectively inhibited tumor growth in vivo with minimal side effects. Furthermore, Y18 exhibited a suitable half-life and oral bioavailability (16.27%), with limited inhibitory activity on CYP isoforms. Taken together, these results suggested that Y18 could be a potential chemotherapeutic drug for cancer treatment, particularly in cases of GTSE1 overexpressed cancers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chemical Biology Research Center at School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325035, Zhejiang, China.
- Chemical Biology Research Center at School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325035, Zhejiang, China. Electronic address: kunwang224@163.com.
- Chemical Biology Research Center at School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325035, Zhejiang, China. Electronic address: lzgcnu@163.com.
- Chemical Biology Research Center at School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325035, Zhejiang, China; The Key Laboratory of Pediatric Hematology and oncology Diseases of Wenzhou, the Second…
Förderung
- Natural Science Foundation of Zhejiang Province
- National Natural Science Foundation of China
Zitieren
APA
Xing, S., Yang, H., Chen, X., Wang, Y., Zhang, S., Wang, P., Chen, C., Wang, K., Liu, Z., & Zheng, X. (2024). Discovery of pyrimidine-2,4-diamine analogues as efficiency anticancer drug by targeting GTSE1. Bioorganic Chemistry, 151, 107700. https://doi.org/10.1016/j.bioorg.2024.107700
Vancouver
Xing S, Yang H, Chen X, Wang Y, Zhang S, Wang P, et al. Discovery of pyrimidine-2,4-diamine analogues as efficiency anticancer drug by targeting GTSE1. Bioorganic Chemistry. 2024;151:107700. doi:10.1016/j.bioorg.2024.107700
BibTeX
@article{Xing2024,
author = {Xing, Sunhui and Yang, Huamao and Chen, Xiaojian and Wang, Yan and Zhang, Shuyuan and Wang, Peipei and Chen, Chaoyue and Wang, Kun and Liu, Zhiguo and Zheng, Xiaohui},
title = {Discovery of pyrimidine-2,4-diamine analogues as efficiency anticancer drug by targeting GTSE1},
journal = {Bioorganic Chemistry},
year = {2024},
volume = {151},
pages = {107700},
doi = {10.1016/j.bioorg.2024.107700}
}
EUVIMED